FARMOVS logo

FARMOVS

FARMOVS can accelerate your product development through innovative ICH GCP compliant phase 1- 2a clinical research.

108 employees · est. 1974 · South Africa

VS
Nova In Silico logo

Nova In Silico

Nova has built jinkō, a unique in silico clinical trial simulation platform to de-risk and accelerate clinical trials

61 employees · est. 2010 · Lyon, France

FARMOVS is the older company (1974 vs 2010).

Side-by-Side Comparison

FARMOVS Nova In Silico
Founded
1974 older 2010
Headquarters
South Africa Lyon, France
Employees
108 61
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Not tracked yet Series A
Total Funding
Not tracked yet $7.50M
Funding Rounds
Not tracked yet 4
Services
Not tracked yet Clinical trial simulation, Disease modeling, In silico research, Data science for drug development, Digital evidence for trials, Market access support
Target Customers
Not tracked yet Pharmaceutical companies, Health technology assessment organizations, Clinical trial experts, Payers
Taxonomy
Clinical Research, Clinical Trials, Phase 1-3, Bioanalytical Laboratory, Pharmacology Research, ICH GCP Compliant, Patient Recruitment, Site Management, Integrated Research, Pharmacogenomic Advice, GLP Certified, Healthy Volunteer Recruitment, Project Management, Quality Assurance In Silico Clinical Trials, Drug Discovery Platform, Clinical Pharmacology, Quantitative Clinical Pharmacology, Systems Biology, Pharmacometrics, Pharmaceutical R&D, Predictive Modeling, Biotech, Pharma, Therapy Optimization, Digital Simulation, Research And Development, Mathematical Modeling, Trial Outcome Prediction
Website
farmovs.com novainsilico.ai
FARMOVS logo

About FARMOVS

FARMOVS is a South Africa-based startup focused on accelerating product development through innovative ICH GCP compliant phase 1-2a clinical research. Established in 2000, the company boasts a rich legacy of over 3000 trials at its world-class clinical research facility. With a large GLP certified b...

Nova In Silico logo

About Nova In Silico

Nova In Silico is a French startup that specializes in providing its unique jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers, and not-for-profit organizations. The platform aims to de-risk and accelerate the R&D of new therapies, ultimately benefit...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at FARMOVS and Nova In Silico — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at FARMOVS and Nova In Silico — by email.

Frequently Asked Questions

FARMOVS — FARMOVS can accelerate your product development through innovative ICH GCP compliant phase 1- 2a clinical research.. Nova In Silico — Nova has built jinkō, a unique in silico clinical trial simulation platform to de-risk and accelerate clinical trials. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
FARMOVS has raised undisclosed funding while Nova In Silico has raised $7.50M.
FARMOVS and Nova In Silico operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare FARMOVS with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy